Trial intelligence / Profile preview

RICE followed by GARD for Relapsed/Refractory DLBCL

NCT00836173Phase 2Withdrawn

Sponsor
Loyola University Chicago
Start
Jul 2008
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gallium nitrate in diffuse large B-cell lymphoma (DLBCL), sponsored by Loyola University Chicago. Planned start Jul 2008; status: withdrawn.

02

Drugs

gallium nitrate
03

Conditions

diffuse large B-cell lymphoma (DLBCL)

Beyond the preview

Go deeper on NCT00836173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00836173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call